A BRD2, BRD4, and BRDT inhibitor; selective over BRD3 and against a panel of 18 BRD proteins; inhibits BRD4 recruitment to androgen receptor-occupied gene enhancer sites inhibiting growth in androgen receptor-dependent prostate cancer cells; induces G1 cell cycle arrest and apoptosis in vitro; efficacious in many xenograft mouse models